News and Announcements
SuiteBox Appoints Chief Revenue Officer
- Published July 14, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
SuiteBox, digital workspace solutions provider and financial advice software company has recently appointed Matt Cave as its new chief revenue officer.
KEY TAKEAWAYS:
- Mr Cave was previously the general manager of Blue Star Group, a division of IVE Group.
- More than 20 years’ experience in sales and marketing along with running his own-start up.
SuiteBox chief executive Ian Dunbar said Mr Cave is a welcome addition into the company, especially since SuiteBox is now gearing up for global expansion.
Mr Cave commented on his appointment by saying that he is looking forward to assisting SuiteBox in their expansion efforts as the new chief revenue officer.
“The opportunity SuiteBox has provided me is incredibly exciting as well as challenging. It is exactly the project I’m seeking,” he said.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
